Medicare Enrolled

Dr. Bradley Icard

Pulmonary Disease · Pinehurst, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
205 PAGE RD, Pinehurst, NC 28374
9102955511
In practice since 2013 (13 years)
NPI: 1720320898 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Icard from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Icard? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Icard

Dr. Bradley Icard is a pulmonary disease specialist in Pinehurst, NC, with 13 years of NPI registration. Based on federal Medicare data, Dr. Icard performed 600 Medicare services across 557 unique beneficiaries.

Between the years covered by Open Payments, Dr. Icard received a total of $111,853 from 36 pharmaceutical and/or device companies across 355 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Icard is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ 600 Medicare services $111,853 industry payments

Medicare Practice Summary

Medicare Utilization ↗
600
Medicare services
Bottom 49% in NC for pulmonary disease
557
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~46 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
80 $90 $260
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
63 $156 $675
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
50 $59 $175
Bronchial secretion aspiration via endoscope
Removal of initial lung airway secretions using an endoscope. This procedure involves inserting a scope into the airways to clear fluid or mucus.
42 $17 $1,150
Computer-assisted navigation of lung airways
This procedure uses computer technology to guide an endoscope through the airways of the lungs for precise navigation.
37 $60 $3,750
Lung biopsy via endoscope, 1 lobe
A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination.
36 $44 $1,450
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
35 $58 $180
Endoscopic needle biopsy of windpipe, airway, or lung
A procedure where a needle is inserted through an endoscope to collect tissue samples from the windpipe, airway, or lung.
32 $127 $2,150
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
30 $101 $395
New patient office visit, complex (60-74 min) 29 $149 $495
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
25 $29 $175
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
25 $42 $155
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
23 $40 $165
Bronchoscopy with ultrasound and growth treatment
A procedure using a flexible tube with a camera and ultrasound to examine the lung airways and treat any growths found.
22 $50 $460
Placement of radiation therapy markers in lung airways
A procedure where small markers are placed into the airways of the lung using an endoscope to assist with radiation therapy targeting.
18 $77 $1,350
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
17 $127 $350
Bronchial irrigation and suction for cell collection
This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing.
12 $14 $1,125
Bronchoscopy with ultrasound and lymph node sampling
A procedure using an endoscope and ultrasound to examine the lung airways and collect samples from 1 to 2 lymph nodes.
12 $117 $895
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
12 $98 $335
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$111,853
Total received (2018-2024)
Avg $15,979/year across 7 years
Top 4% in NC for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
355
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$91,928 (82.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,834 (11.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,091 (6.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$39,091
2023
$56,357
2022
$8,876
2021
$4,481
2020
$1,975
2019
$581
2018
$492

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
INTUITIVE SURGICAL, INC.
$36,509
ABBVIE INC.
$1,442
Galvanize Therapeutics, Inc
$249
GENZYME CORPORATION
$182
ABIOMED
$144
GlaxoSmithKline, LLC.
$134
Insmed, Inc.
$54
Boehringer Ingelheim Pharmaceuticals, Inc.
$52
United Therapeutics Corporation
$41
Actelion Pharmaceuticals US, Inc.
$39
Takeda Pharmaceuticals U.S.A., Inc.
$39
Novartis Pharmaceuticals Corporation
$34
AstraZeneca Pharmaceuticals LP
$34
INOGEN, INC.
$33
Mylan Specialty L.P.
$31
Merck Sharp & Dohme LLC
$29
Grifols USA, LLC
$24
Amgen Inc.
$23
Top 3 companies account for 97.7% of 2024 payments
All-time payments by company (2018-2024) ›
Intuitive Surgical, Inc.
$63,686
INTUITIVE SURGICAL, INC.
$36,509
AstraZeneca Pharmaceuticals LP
$6,481
ABBVIE INC.
$1,492
GlaxoSmithKline, LLC.
$537
Genentech USA, Inc.
$369
GENZYME CORPORATION
$295
Actelion Pharmaceuticals US, Inc.
$262
Galvanize Therapeutics, Inc
$249
Boehringer Ingelheim Pharmaceuticals, Inc.
$183
Amgen Inc.
$167
Novartis Pharmaceuticals Corporation
$162
Regeneron Healthcare Solutions, Inc.
$154
ABIOMED
$144
Mylan Specialty L.P.
$140
United Therapeutics Corporation
$126
Insmed, Inc.
$108
Janssen Pharmaceuticals, Inc
$104
Genentech, Inc.
$93
Takeda Pharmaceuticals U.S.A., Inc.
$79
Merck Sharp & Dohme Corporation
$65
Grifols USA, LLC
$62
Merck Sharp & Dohme LLC
$61
Mallinckrodt Hospital Products Inc.
$44
Shionogi Inc
$41
Teva Pharmaceuticals USA, Inc.
$40
INOGEN, INC.
$33
Inogen, Inc.
$31
La Jolla Pharmaceutical Company
$29
PFIZER INC.
$26
Philips Electronics North America Corporation
$17
PORTOLA PHARMACEUTICALS, INC.
$17
Ambu Inc.
$13
IDORSIA PHARMACEUTICALS US INC
$13
Alexion Pharmaceuticals, Inc.
$12
Allergan Inc.
$11
Top 3 companies account for 95.4% of all-time payments
Associated products mentioned in payments ›
(9547) IGT Systems Undivided · ACTHAR · AIRSUPRA · ALIYA SYSTEM · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Arikayce · BEVESPI AEROSPHERE · BREZTRI · DA VINCI SP · DIFICID · DUPIXENT · Da Vinci Surgical System · FASENRA · Fetroja · GIAPREZA · GLASSIA · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · ION · Impella · InogenOne · LOKELMA · LUMAKRAS · NUCALA · OFEV · OPSUMIT · Prolastin-C Liquid · QUVIVIQ · SOLIRIS · STIOLTO RESPIMAT · SYMBICORT · TAGRISSO · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · UPTRAVI · XARELTO · XOLAIR · Xolair · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (82%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for pulmonary disease in NC.

Looking for a pulmonary disease specialist in Pinehurst?
Compare pulmonary diseases in the Pinehurst area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
9
Per 100K population
8.8
County median income
$82,837
Nearest hospital
FIRSTHEALTH MOORE REGIONAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Icard is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 4% of NC peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Icard experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Icard performed 80 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Icard receive payments from pharmaceutical companies?
Yes. Dr. Icard received a total of $111,853 from 36 companies across 355 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Icard's costs compare to other pulmonary diseases in Pinehurst?
Dr. Icard's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Icard) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →